Cargando…

Mesothelioma : risk factors, treatment and prognosis /

"Mesothelioma is a type of cancer in which tumors form in the tissue that lines the lungs, heart, stomach, and other organs. While mesothelioma is relatively rare, it represents a serious health crisis as the disease is aggressive and often fatal. This book includes five chapters that detail th...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Martin, Albert K. (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: New York : Nova Science Publishers, [2021]
Colección:Cancer etiology, diagnosis and treatments
Temas:
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Intro
  • Contents
  • Preface
  • Chapter 1
  • Mesothelioma: The Advent of Immunotherapy
  • Abstract
  • Introduction
  • Rationale: Immune Cells Orchestra inside Mesothelioma Tumor Microenvironment
  • Immune Check-Point Inhibitors
  • Brief History of Immunotherapy in Malignant Pleural Mesothelioma
  • Advent of Immune Checkpoint Inhibitors
  • Checkpoint Inhibitor within the Salvage Setting
  • Anti-CTLA4
  • Anti-PD1
  • Anti PD-L1
  • Combination of Checkpoint Inhibitors
  • Checkpoint Inhibitors within the First-Line Setting
  • Combination of Checkpoint Inhibitors
  • Other Immunotherapies
  • Vaccines
  • Cellular Immunotherapy
  • Conclusion
  • References
  • Chapter 2
  • Malignant Mesothelioma
  • Abstract
  • Introduction
  • Risk Factors
  • Asbestos
  • People Most at Risk of an Asbestos-Related Disease
  • Non-Occupational Exposure
  • Histopathology and Pathophysiology
  • Presentation
  • Evaluation
  • Treatment
  • Preventive Measures
  • Curative Measures
  • Surgical
  • Malignant Mesothelioma of Tunica Vaginalis
  • Malignant Pleural Mesothelioma
  • Chemotherapy
  • Radiotherapy
  • Recommendation
  • Targeted Therapy
  • Gene Therapy
  • Photodynamic Therapy
  • Immunotherapy
  • Virus Therapies
  • Prognosis
  • References
  • Chapter 3
  • Inflammatory and Immunological Aspects in the Surgical Management of Malignant Pleural Mesothelioma
  • Abstract
  • Introduction
  • Prognostic Role of Inflammatory and Immunological Markers
  • Blood
  • Platelets Count
  • White Blood Cell Count
  • White Blood Cell Differential
  • Hemoglobin
  • Red Cell Distribution Width (RDW)
  • Ratios
  • Neutrophil-to-Lymphocyte Ratio
  • Platelet-to-Lymphocyte Ratio
  • Lymphocyte-to-Monocyte Ratio (LMR)
  • Osteopontin (OPN)
  • Prognostic Groups
  • Cancer and Leukemia Group B
  • European Organization for Research and Treatment of Cancer (EORTC)
  • Modified Glasgow Prognostic Score (mGPS).
  • Prognostic Risk Classification (PRC)
  • Effects of Inflammation on Quality of Life
  • Surgery Related Inflammatory and Immune Impairment in Cancer
  • Conclusion
  • References
  • Biographical Sketch
  • Chapter 4
  • New Developments in Mesothelioma Markers
  • Abstract
  • Introduction
  • Malignant Mesothelioma
  • Asbestos
  • Cancer Markers
  • Biochemical Indicators Linked to Cancer Development
  • Cancer Markers in Malignant Mesothelioma
  • Immunochemical Markers
  • Genetic Markers
  • Soluble Markers of Mesothelioma
  • Mesothelin
  • Fibulin-3
  • Osteopontin and RANTES
  • New Biomarkers
  • Epigenetics and miRNA
  • Conclusion
  • References
  • Chapter 5
  • Surgical Approaches to Pleural Tumours
  • Abstract
  • Introduction
  • Benign Tumours
  • Clinical Presentation
  • Diagnosis
  • Therapy
  • Malignant Tumours
  • Epidemiology and Aetiology
  • Exposure to Asbestos
  • Other Risk Factors
  • Clinical Presentation
  • Diagnosis
  • Chest X-Ray
  • Chest CT Scan with Contrast Enhancement
  • 18-Fluorodeoxyglucose Positron Emission Tomography with (18FDG-PET)
  • Magnetic Resonance Imaging (MRI)
  • Other Radiological Methods
  • Tumour Marker Evaluation in Pleural Fluid
  • Cytological Examination of Pleural Fluid
  • Pathological Anatomy
  • Prognosis and Staging
  • Treatment
  • References
  • Index
  • Blank Page.